News Release

USPSTF recommends PrEP to prevent HIV infection in people at high risk

Peer-Reviewed Publication

JAMA Network

Bottom Line: In a new recommendation, the U.S. Preventive Services Task Force (USPSTF) recommends clinicians offer preexposure prophylaxis (PrEP) with effective antiretroviral therapy to people at high risk of acquiring HIV to decrease their risk of infection with the virus that causes AIDS. The USPSTF routinely makes recommendations about the effectiveness of preventive care services. This recommendation statement comes after a review of the evidence on the benefits of PrEP to prevent HIV infection. There were more than 38,000 new diagnoses of HIV infection reported in the United States in 2017. HIV is now treatable but there is no cure and the virus can have significant health consequences.

(doi:10.1001/jama.2019.6390)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Note: More information about the U.S. Preventive Services Task Force, its process, and its recommendations can be found on the newsroom page of its website.

###

Embed this link to provide your readers free access to the full-text article: This link will be live at the embargo time and all USPSTF articles remain free indefinitely: https://jamanetwork.com/journals/jama/fullarticle/2735509?guestAccessKey=e7dfb28b-1d9c-4351-ba42-964c790a443f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=061119


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.